
SUZHOU,China,Dec. 27,2024-- Alphamab Oncology (stock code: 9966.HK) announced that anti-HER2 bispecific antibody-drug conjugate (ADC) JSKN003 has received approval from the Center for Drug Evaluation
SUZHOU,China,Dec. 27,2024-- Alphamab Oncology (stock code: 9966.HK) announced that anti-HER2 bispecific antibody-drug conjugate (ADC) JSKN003 has received approval from the Center for Drug Evaluation
Wonderful Indonesia Co-Branding: A Kaleidoscope of Achievements in 2024
JAKARTA,Indonesia,Dec. 30,2024-- The Ministry of Tourism and Creative Economy has highlighted key achievements from its Wonderful Indonesia Co-Branding partnership in 2024. The program has effectively
Designs For Health Inc. Held Liable For Infringement of Kaneka's Ubiquinol Patent
TOKYO,Dec. 25,2024-- Kaneka has successfully defended its patent for stabilizing Ubiquinol.On December 20,2024,Kaneka Corporation won its lawsuit against Designs for Health,Inc. and American River Nu
Chancay Port serves as bridge between South America and Asia
BEIJING,Dec. 26,2024-- A report from People\'s Daily: Gonzalo Rios is the deputy general manager of COSCO Shipping Ports Chancay Peru S.A.
Lichen China Limited Announces $2.8 Million Registered Direct Offering
XIAMEN,China,Dec. 27,2024--Lichen China Limited (Nasdaq: LICN)("Lichen China" or the "Company"),a dedicated financial and taxation service provider inChina today announced that it
HSG Laser Opens New Manufacturing Facility in Jinan, China and Unveils 120kW Laser Cutter
CHICAGO,Dec. 26,2024-- HSG Laser,a global leader in metal shaping equipment and solutions,proudly announces the grand opening of its newest manufacturing facility in Jinan,China—a key milestone in it
Thinkfree showcases AI-Driven future workplace at CES 2025
LAS VEGAS and SEOUL,South Korea,Dec. 27,2024--Thinkfree,a global software company in productivity tools and AI technology,will participate in CES 2025,taking place in Las Vegas from January 7 to Janu
SUZHOU,China,Dec. 27,2024-- Alphamab Oncology (stock code: 9966.HK) announced that anti-HER2 bispecific antibody-drug conjugate (ADC) JSKN003 has received approval from the Center for Drug Evaluation
ARTERY 2024: Redefining MCU Innovation for a Smarter Future
TAIPEI,Dec. 30,2024-- As the calendar turns,ARTERY Technology extends warm New Year greetings! In 2024,leveraging professional expertise and technological breakthroughs,we made steady progress in a ra
Ractigen Therapeutics Founder Dr. Long-Cheng Li Awarded 2024 Life Science Ice Breaking Award
NANTONG and SUZHOU,China,Dec. 31,2024-- Ractigen Therapeutics proudly announces that its Founder and CEO,Dr. Long-Cheng Li,has been honored with the 2024 Life Science Ice Breaking Award. This award,es